A report on lung tissue and serum demonstrates that DEN treatment increased COX-2, TNF-α, and IL-6 levels [61], while others have shown elevated tumor markers (e.g., carcinoembryonic antigen, CEA) [62]. The gene discussed is CEACAM5; the disease is neoplasm.